| 注册
首页|期刊导航|中华医学杂志(英文版)|Efficacy and safety of decitabine combined with low-dose cytarabine,aclarubicin,and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation

Efficacy and safety of decitabine combined with low-dose cytarabine,aclarubicin,and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation

Si-Si Chen Qian Sun Lan Cao Wen-Zhong Wu Yue Xie Chun Qiao Jian-Yong Li Si-Xuan Qian Ming Hong

中华医学杂志(英文版)2021,Vol.134Issue(12):1477-1479,3.
中华医学杂志(英文版)2021,Vol.134Issue(12):1477-1479,3.DOI:10.1097/CM9.0000000000001316

Efficacy and safety of decitabine combined with low-dose cytarabine,aclarubicin,and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation

Efficacy and safety of decitabine combined with low-dose cytarabine,aclarubicin,and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation

Si-Si Chen 1Qian Sun 2Lan Cao 3Wen-Zhong Wu 4Yue Xie 5Chun Qiao 2Jian-Yong Li 3Si-Xuan Qian 4Ming Hong6

作者信息

  • 1. Department of Hematology,The Affiliated Yixing Hospital of Jiangsu University,Wuxi,Jiangsu 214200,China
  • 2. Department of Hematology,The First Affiliated Hospital of Nanjing Medical University,Jiangsu Province Hospital,Nanjing,Jiangsu 210029,China
  • 3. Key Laboratory of Hematology of Nanjing Medical University,Nanjing,Jiangsu 210029,China
  • 4. Collaborative Innovation Center for Cancer Personalized Medicine,Nanjing,Jiangsu 210029,China
  • 5. pukou CLL Center,Pukou division of Jiangsu Province Hospital,Nanjing,Jiangsu 211899,China
  • 6. Pukou CLL Center,Pukou division of Jiangsu Province Hospital,Nanjing,Jiangsu 211899,China
  • 折叠

摘要

引用本文复制引用

Si-Si Chen,Qian Sun,Lan Cao,Wen-Zhong Wu,Yue Xie,Chun Qiao,Jian-Yong Li,Si-Xuan Qian,Ming Hong..Efficacy and safety of decitabine combined with low-dose cytarabine,aclarubicin,and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation[J].中华医学杂志(英文版),2021,134(12):1477-1479,3.

基金项目

This work was supported by the National Natural Science Foundation of China (Nos.81870119 and 81720108002),the National Science and Technology Major Project (No.2018ZX09734007),and the Clinical Medicine and Technological Development Foundation of Jiangsu Uni-versity (No.JLY20180072). (Nos.81870119 and 81720108002)

中华医学杂志(英文版)

OACSCDCSTPCDMEDLINESCI

0366-6999

访问量0
|
下载量0
段落导航相关论文